Burney Company’s Exact Sciences EXAS Stock Holding History

Burney Company’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,063	Closed	-$1.34M	–	605
2023 Q4	$1.34M	Buy	+18,063	New	+$1.18M	0.06%	288

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Burney Company's EXAS Position: Q1 2024 in Review

Burney Company sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 18,063 shares — an estimated $1.34M sold.

Burney Company first reported a position in EXAS in Q4 2023 and held it in 1 quarter. The position peaked at $1.34M in Q4 2023. 626 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

Burney Company reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
Burney Company sold 18,063 Exact Sciences shares in Q1 2024, an estimated $1.34M.
Burney Company first reported a position in Exact Sciences in Q4 2023 and held it in 1 quarter.
Burney Company's Exact Sciences position peaked at $1.34M in Q4 2023.
626 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Burney Company's 13F filing for Q1 2024, filed 22 May 2024.